img

Global Carbapenem Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Carbapenem Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Carbapenem market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Carbapenem is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Carbapenem is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Carbapenem is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Carbapenem include Pfizer, Savior Lifetec, Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical and United Lab, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Carbapenem, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Carbapenem by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Carbapenem market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Carbapenem market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Pfizer
Savior Lifetec
Sun Pharmaceutical Industries
Kopran
HISUN Pharmaceutical
Haibin Pharmaceutical
United Lab
By Type
Meropenem
Doripenem
Imipenem
Panipenem
Others
By Application
Hosptials
Clinics
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Carbapenem in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Carbapenem manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Carbapenem sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Carbapenem Definition
1.2 Market by Type
1.2.1 Global Carbapenem Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Meropenem
1.2.3 Doripenem
1.2.4 Imipenem
1.2.5 Panipenem
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Carbapenem Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hosptials
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Carbapenem Sales
2.1 Global Carbapenem Revenue Estimates and Forecasts 2018-2034
2.2 Global Carbapenem Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Carbapenem Revenue by Region
2.3.1 Global Carbapenem Revenue by Region (2018-2024)
2.3.2 Global Carbapenem Revenue by Region (2024-2034)
2.4 Global Carbapenem Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Carbapenem Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Carbapenem Sales Quantity by Region
2.6.1 Global Carbapenem Sales Quantity by Region (2018-2024)
2.6.2 Global Carbapenem Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Carbapenem Sales Quantity by Manufacturers
3.1.1 Global Carbapenem Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Carbapenem Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Carbapenem Sales in 2022
3.2 Global Carbapenem Revenue by Manufacturers
3.2.1 Global Carbapenem Revenue by Manufacturers (2018-2024)
3.2.2 Global Carbapenem Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Carbapenem Revenue in 2022
3.3 Global Carbapenem Sales Price by Manufacturers
3.4 Global Key Players of Carbapenem, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Carbapenem Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Carbapenem, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Carbapenem, Product Offered and Application
3.8 Global Key Manufacturers of Carbapenem, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Carbapenem Sales Quantity by Type
4.1.1 Global Carbapenem Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Carbapenem Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Carbapenem Sales Quantity Market Share by Type (2018-2034)
4.2 Global Carbapenem Revenue by Type
4.2.1 Global Carbapenem Historical Revenue by Type (2018-2024)
4.2.2 Global Carbapenem Forecasted Revenue by Type (2024-2034)
4.2.3 Global Carbapenem Revenue Market Share by Type (2018-2034)
4.3 Global Carbapenem Price by Type
4.3.1 Global Carbapenem Price by Type (2018-2024)
4.3.2 Global Carbapenem Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Carbapenem Sales Quantity by Application
5.1.1 Global Carbapenem Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Carbapenem Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Carbapenem Sales Quantity Market Share by Application (2018-2034)
5.2 Global Carbapenem Revenue by Application
5.2.1 Global Carbapenem Historical Revenue by Application (2018-2024)
5.2.2 Global Carbapenem Forecasted Revenue by Application (2024-2034)
5.2.3 Global Carbapenem Revenue Market Share by Application (2018-2034)
5.3 Global Carbapenem Price by Application
5.3.1 Global Carbapenem Price by Application (2018-2024)
5.3.2 Global Carbapenem Price Forecast by Application (2024-2034)
6 North America
6.1 North America Carbapenem Sales by Company
6.1.1 North America Carbapenem Revenue by Company (2018-2024)
6.1.2 North America Carbapenem Sales Quantity by Company (2018-2024)
6.2 North America Carbapenem Market Size by Type
6.2.1 North America Carbapenem Sales Quantity by Type (2018-2034)
6.2.2 North America Carbapenem Revenue by Type (2018-2034)
6.3 North America Carbapenem Market Size by Application
6.3.1 North America Carbapenem Sales Quantity by Application (2018-2034)
6.3.2 North America Carbapenem Revenue by Application (2018-2034)
6.4 North America Carbapenem Market Size by Country
6.4.1 North America Carbapenem Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Carbapenem Revenue by Country (2018-2034)
6.4.3 North America Carbapenem Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Carbapenem Sales by Company
7.1.1 Europe Carbapenem Sales Quantity by Company (2018-2024)
7.1.2 Europe Carbapenem Revenue by Company (2018-2024)
7.2 Europe Carbapenem Market Size by Type
7.2.1 Europe Carbapenem Sales Quantity by Type (2018-2034)
7.2.2 Europe Carbapenem Revenue by Type (2018-2034)
7.3 Europe Carbapenem Market Size by Application
7.3.1 Europe Carbapenem Sales Quantity by Application (2018-2034)
7.3.2 Europe Carbapenem Revenue by Application (2018-2034)
7.4 Europe Carbapenem Market Size by Country
7.4.1 Europe Carbapenem Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Carbapenem Revenue by Country (2018-2034)
7.4.3 Europe Carbapenem Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Carbapenem Sales by Company
8.1.1 China Carbapenem Sales Quantity by Company (2018-2024)
8.1.2 China Carbapenem Revenue by Company (2018-2024)
8.2 China Carbapenem Market Size by Type
8.2.1 China Carbapenem Sales Quantity by Type (2018-2034)
8.2.2 China Carbapenem Revenue by Type (2018-2034)
8.3 China Carbapenem Market Size by Application
8.3.1 China Carbapenem Sales Quantity by Application (2018-2034)
8.3.2 China Carbapenem Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Carbapenem Sales by Company
9.1.1 APAC Carbapenem Sales Quantity by Company (2018-2024)
9.1.2 APAC Carbapenem Revenue by Company (2018-2024)
9.2 APAC Carbapenem Market Size by Type
9.2.1 APAC Carbapenem Sales Quantity by Type (2018-2034)
9.2.2 APAC Carbapenem Revenue by Type (2018-2034)
9.3 APAC Carbapenem Market Size by Application
9.3.1 APAC Carbapenem Sales Quantity by Application (2018-2034)
9.3.2 APAC Carbapenem Revenue by Application (2018-2034)
9.4 APAC Carbapenem Market Size by Region
9.4.1 APAC Carbapenem Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Carbapenem Revenue by Region (2018-2034)
9.4.3 APAC Carbapenem Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Carbapenem Sales by Company
10.1.1 Middle East, Africa and Latin America Carbapenem Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Carbapenem Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Carbapenem Market Size by Type
10.2.1 Middle East, Africa and Latin America Carbapenem Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Carbapenem Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Carbapenem Market Size by Application
10.3.1 Middle East, Africa and Latin America Carbapenem Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Carbapenem Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Carbapenem Market Size by Country
10.4.1 Middle East, Africa and Latin America Carbapenem Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Carbapenem Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Carbapenem Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Carbapenem Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Pfizer Carbapenem Products and Services
11.1.5 Pfizer Carbapenem SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Savior Lifetec
11.2.1 Savior Lifetec Company Information
11.2.2 Savior Lifetec Overview
11.2.3 Savior Lifetec Carbapenem Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Savior Lifetec Carbapenem Products and Services
11.2.5 Savior Lifetec Carbapenem SWOT Analysis
11.2.6 Savior Lifetec Recent Developments
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Information
11.3.2 Sun Pharmaceutical Industries Overview
11.3.3 Sun Pharmaceutical Industries Carbapenem Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Sun Pharmaceutical Industries Carbapenem Products and Services
11.3.5 Sun Pharmaceutical Industries Carbapenem SWOT Analysis
11.3.6 Sun Pharmaceutical Industries Recent Developments
11.4 Kopran
11.4.1 Kopran Company Information
11.4.2 Kopran Overview
11.4.3 Kopran Carbapenem Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Kopran Carbapenem Products and Services
11.4.5 Kopran Carbapenem SWOT Analysis
11.4.6 Kopran Recent Developments
11.5 HISUN Pharmaceutical
11.5.1 HISUN Pharmaceutical Company Information
11.5.2 HISUN Pharmaceutical Overview
11.5.3 HISUN Pharmaceutical Carbapenem Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 HISUN Pharmaceutical Carbapenem Products and Services
11.5.5 HISUN Pharmaceutical Carbapenem SWOT Analysis
11.5.6 HISUN Pharmaceutical Recent Developments
11.6 Haibin Pharmaceutical
11.6.1 Haibin Pharmaceutical Company Information
11.6.2 Haibin Pharmaceutical Overview
11.6.3 Haibin Pharmaceutical Carbapenem Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Haibin Pharmaceutical Carbapenem Products and Services
11.6.5 Haibin Pharmaceutical Carbapenem SWOT Analysis
11.6.6 Haibin Pharmaceutical Recent Developments
11.7 United Lab
11.7.1 United Lab Company Information
11.7.2 United Lab Overview
11.7.3 United Lab Carbapenem Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 United Lab Carbapenem Products and Services
11.7.5 United Lab Carbapenem SWOT Analysis
11.7.6 United Lab Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Carbapenem Value Chain Analysis
12.2 Carbapenem Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Carbapenem Production Mode & Process
12.4 Carbapenem Sales and Marketing
12.4.1 Carbapenem Sales Channels
12.4.2 Carbapenem Distributors
12.5 Carbapenem Customers
13 Market Dynamics
13.1 Carbapenem Industry Trends
13.2 Carbapenem Market Drivers
13.3 Carbapenem Market Challenges
13.4 Carbapenem Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Carbapenem Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Meropenem
Table 3. Major Manufacturers of Doripenem
Table 4. Major Manufacturers of Imipenem
Table 5. Major Manufacturers of Panipenem
Table 6. Major Manufacturers of Others
Table 7. Global Carbapenem Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Carbapenem Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Carbapenem Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Carbapenem Revenue Market Share by Region (2018-2024)
Table 11. Global Carbapenem Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Carbapenem Revenue Market Share by Region (2024-2034)
Table 13. Global Carbapenem Sales Quantity by Region: 2018 VS 2022 VS 2034 (MT)
Table 14. Global Carbapenem Sales by Region (2018-2024) & (MT)
Table 15. Global Carbapenem Sales Market Share by Region (2018-2024)
Table 16. Global Carbapenem Sales by Region (2024-2034) & (MT)
Table 17. Global Carbapenem Sales Market Share by Region (2024-2034)
Table 18. Global Carbapenem Sales Quantity by Manufacturers (2018-2024) & (MT)
Table 19. Global Carbapenem Sales Quantity Share by Manufacturers (2018-2024)
Table 20. Global Carbapenem Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Carbapenem Revenue Share by Manufacturers (2018-2024)
Table 22. Global Carbapenem Price by Manufacturers 2018-2024 (USD/Kg)
Table 23. Global Key Players of Carbapenem, Industry Ranking, 2021 VS 2022
Table 24. Global Carbapenem Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Carbapenem by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carbapenem as of 2022)
Table 26. Global Key Manufacturers of Carbapenem, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Carbapenem, Product Offered and Application
Table 28. Global Key Manufacturers of Carbapenem, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Carbapenem Sales Quantity by Type (2018-2024) & (MT)
Table 31. Global Carbapenem Sales Quantity by Type (2024-2034) & (MT)
Table 32. Global Carbapenem Sales Quantity Share by Type (2018-2024)
Table 33. Global Carbapenem Sales Quantity Share by Type (2024-2034)
Table 34. Global Carbapenem Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Carbapenem Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Carbapenem Revenue Share by Type (2018-2024)
Table 37. Global Carbapenem Revenue Share by Type (2024-2034)
Table 38. Carbapenem Price by Type (2018-2024) & (USD/Kg)
Table 39. Global Carbapenem Price Forecast by Type (2024-2034) & (USD/Kg)
Table 40. Global Carbapenem Sales Quantity by Application (2018-2024) & (MT)
Table 41. Global Carbapenem Sales Quantity by Application (2024-2034) & (MT)
Table 42. Global Carbapenem Sales Quantity Share by Application (2018-2024)
Table 43. Global Carbapenem Sales Quantity Share by Application (2024-2034)
Table 44. Global Carbapenem Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Carbapenem Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Carbapenem Revenue Share by Application (2018-2024)
Table 47. Global Carbapenem Revenue Share by Application (2024-2034)
Table 48. Carbapenem Price by Application (2018-2024) & (USD/Kg)
Table 49. Global Carbapenem Price Forecast by Application (2024-2034) & (USD/Kg)
Table 50. North America Carbapenem Revenue by Company (2018-2024) & (US$ Million)
Table 51. North America Carbapenem Sales Quantity by Company (2018-2024) & (MT)
Table 52. North America Carbapenem Sales Quantity by Type (2018-2024) & (MT)
Table 53. North America Carbapenem Sales Quantity by Type (2024-2034) & (MT)
Table 54. North America Carbapenem Revenue by Type (2018-2024) & (US$ Million)
Table 55. North America Carbapenem Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Carbapenem Sales Quantity by Application (2018-2024) & (MT)
Table 57. North America Carbapenem Sales Quantity by Application (2024-2034) & (MT)
Table 58. North America Carbapenem Revenue by Application (2018-2024) & (US$ Million)
Table 59. North America Carbapenem Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Carbapenem Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. North America Carbapenem Revenue by Country (2018-2024) & (US$ Million)
Table 62. North America Carbapenem Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Carbapenem Sales Quantity by Country (2018-2024) & (MT)
Table 64. North America Carbapenem Sales Quantity by Country (2024-2034) & (MT)
Table 65. Europe Carbapenem Sales Quantity by Company (2018-2024) & (MT)
Table 66. Europe Carbapenem Revenue by Company (2018-2024) & (US$ Million)
Table 67. Europe Carbapenem Sales Quantity by Type (2018-2024) & (MT)
Table 68. Europe Carbapenem Sales Quantity by Type (2024-2034) & (MT)
Table 69. Europe Carbapenem Revenue by Type (2018-2024) & (US$ Million)
Table 70. Europe Carbapenem Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Carbapenem Sales Quantity by Application (2018-2024) & (MT)
Table 72. Europe Carbapenem Sales Quantity by Application (2024-2034) & (MT)
Table 73. Europe Carbapenem Revenue by Application (2018-2024) & (US$ Million)
Table 74. Europe Carbapenem Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Carbapenem Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 76. Europe Carbapenem Revenue by Country (2018-2024) & (US$ Million)
Table 77. Europe Carbapenem Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Carbapenem Sales Quantity by Country (2018-2024) & (MT)
Table 79. Europe Carbapenem Sales Quantity by Country (2024-2034) & (MT)
Table 80. China Carbapenem Sales Quantity by Company (2018-2024) & (MT)
Table 81. China Carbapenem Revenue by Company (2018-2024) & (US$ Million)
Table 82. China Carbapenem Sales Quantity by Type (2018-2024) & (MT)
Table 83. China Carbapenem Sales Quantity by Type (2024-2034) & (MT)
Table 84. China Carbapenem Revenue by Type (2018-2024) & (US$ Million)
Table 85. China Carbapenem Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Carbapenem Sales Quantity by Application (2018-2024) & (MT)
Table 87. China Carbapenem Sales Quantity by Application (2024-2034) & (MT)
Table 88. China Carbapenem Revenue by Application (2018-2024) & (US$ Million)
Table 89. China Carbapenem Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Carbapenem Sales Quantity by Company (2018-2024) & (MT)
Table 91. APAC Carbapenem Revenue by Company (2018-2024) & (US$ Million)
Table 92. APAC Carbapenem Sales Quantity by Type (2018-2024) & (MT)
Table 93. APAC Carbapenem Sales Quantity by Type (2024-2034) & (MT)
Table 94. APAC Carbapenem Revenue by Type (2018-2024) & (US$ Million)
Table 95. APAC Carbapenem Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Carbapenem Sales Quantity by Application (2018-2024) & (MT)
Table 97. APAC Carbapenem Sales Quantity by Application (2024-2034) & (MT)
Table 98. APAC Carbapenem Revenue by Application (2018-2024) & (US$ Million)
Table 99. APAC Carbapenem Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Carbapenem Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 101. APAC Carbapenem Revenue by Region (2018-2024) & (US$ Million)
Table 102. APAC Carbapenem Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Carbapenem Sales Quantity by Region (2018-2024) & (MT)
Table 104. APAC Carbapenem Sales Quantity by Region (2024-2034) & (MT)
Table 105. Middle East, Africa and Latin America Carbapenem Sales Quantity by Company (2018-2024) & (MT)
Table 106. Middle East, Africa and Latin America Carbapenem Revenue by Company (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Carbapenem Sales Quantity by Type (2018-2024) & (MT)
Table 108. Middle East, Africa and Latin America Carbapenem Sales Quantity by Type (2024-2034) & (MT)
Table 109. Middle East, Africa and Latin America Carbapenem Revenue by Type (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Carbapenem Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Carbapenem Sales Quantity by Application (2018-2024) & (MT)
Table 112. Middle East, Africa and Latin America Carbapenem Sales Quantity by Application (2024-2034) & (MT)
Table 113. Middle East, Africa and Latin America Carbapenem Revenue by Application (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Carbapenem Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Carbapenem Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Carbapenem Revenue by Country (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Carbapenem Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Carbapenem Sales Quantity by Country (2018-2024) & (MT)
Table 119. Middle East, Africa and Latin America Carbapenem Sales Quantity by Country (2024-2034) & (MT)
Table 120. Pfizer Company Information
Table 121. Pfizer Description and Overview
Table 122. Pfizer Carbapenem Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 123. Pfizer Carbapenem Product and Services
Table 124. Pfizer Carbapenem SWOT Analysis
Table 125. Pfizer Recent Developments
Table 126. Savior Lifetec Company Information
Table 127. Savior Lifetec Description and Overview
Table 128. Savior Lifetec Carbapenem Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 129. Savior Lifetec Carbapenem Product and Services
Table 130. Savior Lifetec Carbapenem SWOT Analysis
Table 131. Savior Lifetec Recent Developments
Table 132. Sun Pharmaceutical Industries Company Information
Table 133. Sun Pharmaceutical Industries Description and Overview
Table 134. Sun Pharmaceutical Industries Carbapenem Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 135. Sun Pharmaceutical Industries Carbapenem Product and Services
Table 136. Sun Pharmaceutical Industries Carbapenem SWOT Analysis
Table 137. Sun Pharmaceutical Industries Recent Developments
Table 138. Kopran Company Information
Table 139. Kopran Description and Overview
Table 140. Kopran Carbapenem Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 141. Kopran Carbapenem Product and Services
Table 142. Kopran Carbapenem SWOT Analysis
Table 143. Kopran Recent Developments
Table 144. HISUN Pharmaceutical Company Information
Table 145. HISUN Pharmaceutical Description and Overview
Table 146. HISUN Pharmaceutical Carbapenem Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 147. HISUN Pharmaceutical Carbapenem Product and Services
Table 148. HISUN Pharmaceutical Carbapenem SWOT Analysis
Table 149. HISUN Pharmaceutical Recent Developments
Table 150. Haibin Pharmaceutical Company Information
Table 151. Haibin Pharmaceutical Description and Overview
Table 152. Haibin Pharmaceutical Carbapenem Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 153. Haibin Pharmaceutical Carbapenem Product and Services
Table 154. Haibin Pharmaceutical Carbapenem SWOT Analysis
Table 155. Haibin Pharmaceutical Recent Developments
Table 156. United Lab Company Information
Table 157. United Lab Description and Overview
Table 158. United Lab Carbapenem Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 159. United Lab Carbapenem Product and Services
Table 160. United Lab Carbapenem SWOT Analysis
Table 161. United Lab Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Carbapenem Distributors List
Table 165. Carbapenem Customers List
Table 166. Carbapenem Market Trends
Table 167. Carbapenem Market Drivers
Table 168. Carbapenem Market Challenges
Table 169. Carbapenem Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Carbapenem Product Picture
Figure 2. Global Carbapenem Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Carbapenem Market Share by Type in 2022 & 2034
Figure 4. Meropenem Product Picture
Figure 5. Doripenem Product Picture
Figure 6. Imipenem Product Picture
Figure 7. Panipenem Product Picture
Figure 8. Others Product Picture
Figure 9. Global Carbapenem Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Carbapenem Market Share by Application in 2022 & 2034
Figure 11. Hosptials
Figure 12. Clinics
Figure 13. Others
Figure 14. Carbapenem Report Years Considered
Figure 15. Global Carbapenem Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Carbapenem Revenue 2018-2034 (US$ Million)
Figure 17. Global Carbapenem Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Carbapenem Sales Quantity 2018-2034 (MT)
Figure 19. Global Carbapenem Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Carbapenem Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Carbapenem Sales Quantity YoY (2018-2034) & (MT)
Figure 22. North America Carbapenem Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Carbapenem Sales Quantity YoY (2018-2034) & (MT)
Figure 24. Europe Carbapenem Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Carbapenem Sales Quantity YoY (2018-2034) & (MT)
Figure 26. China Carbapenem Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Carbapenem Sales Quantity YoY (2018-2034) & (MT)
Figure 28. APAC Carbapenem Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Carbapenem Sales Quantity YoY (2018-2034) & (MT)
Figure 30. Middle East, Africa and Latin America Carbapenem Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Carbapenem Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Carbapenem Revenue in 2022
Figure 33. Carbapenem Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Carbapenem Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Carbapenem Revenue Market Share by Type (2018-2034)
Figure 36. Global Carbapenem Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Carbapenem Revenue Market Share by Application (2018-2034)
Figure 38. North America Carbapenem Revenue Market Share by Company in 2022
Figure 39. North America Carbapenem Sales Quantity Market Share by Company in 2022
Figure 40. North America Carbapenem Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Carbapenem Revenue Market Share by Type (2018-2034)
Figure 42. North America Carbapenem Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Carbapenem Revenue Market Share by Application (2018-2034)
Figure 44. North America Carbapenem Revenue Share by Country (2018-2034)
Figure 45. North America Carbapenem Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Carbapenem Sales Quantity Market Share by Company in 2022
Figure 49. Europe Carbapenem Revenue Market Share by Company in 2022
Figure 50. Europe Carbapenem Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Carbapenem Revenue Market Share by Type (2018-2034)
Figure 52. Europe Carbapenem Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Carbapenem Revenue Market Share by Application (2018-2034)
Figure 54. Europe Carbapenem Revenue Share by Country (2018-2034)
Figure 55. Europe Carbapenem Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 57. France Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 61. China Carbapenem Sales Quantity Market Share by Company in 2022
Figure 62. China Carbapenem Revenue Market Share by Company in 2022
Figure 63. China Carbapenem Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Carbapenem Revenue Market Share by Type (2018-2034)
Figure 65. China Carbapenem Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Carbapenem Revenue Market Share by Application (2018-2034)
Figure 67. APAC Carbapenem Sales Quantity Market Share by Company in 2022
Figure 68. APAC Carbapenem Revenue Market Share by Company in 2022
Figure 69. APAC Carbapenem Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Carbapenem Revenue Market Share by Type (2018-2034)
Figure 71. APAC Carbapenem Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Carbapenem Revenue Market Share by Application (2018-2034)
Figure 73. APAC Carbapenem Revenue Share by Region (2018-2034)
Figure 74. APAC Carbapenem Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 79. India Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Carbapenem Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Carbapenem Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Carbapenem Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Carbapenem Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Carbapenem Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Carbapenem Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Carbapenem Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Carbapenem Revenue Share by Country (2018-2034)
Figure 88. Brazil Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Carbapenem Revenue (2018-2034) & (US$ Million)
Figure 93. Carbapenem Value Chain
Figure 94. Carbapenem Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed